Education Library

Vasileios Panoulas, MD, discusses an individual patient data pooling from the PROTECT II RCT, PROTECT III and RESTORE EF trials released at EuroPCR 2023.

Prof. Dr. Evgenij V. Potapov discusses combining extracorporeal life support (ECLS) with pMCS for treating advanced cardiogenic shock.

Alaide Chieffo, MD, discusses results from a subanalysis of women in the IMP-IT Registry in Italy.

Are there billable services after Impella® insertion in the cath lab, such as ICU monitoring?

Jacob Abraham, MD, Raymond Lee, MD, and Bindu Akkanti, MD, discuss ECpella therapy in this CAMP webinar moderated by Misty Casseus, MSN, RN.

Rohan Goswami, MD, discusses renal recovery in patients with heart failure cardiogenic shock (HFCS) supported with Impella 5.5® with SmartAssist®.

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.

Jay Giri, MD, discusses the pros, cons, and best uses for five types of observational database analyses.

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.

Jason Wollmuth, MD, describes best practice techniques for Impella-supported complete revascularization in a RESTORE EF case.

William O’Neill, MD, discusses the need for designing programs to improve outcomes in patients with AMI cardiogenic shock.

Babar Basir, MD, discusses how hemodynamics can help clinicians decide whether to use mechanical circulatory support (MCS) in patients undergoing high-risk PCI.

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.